Wave Life Sciences WVE
NASDAQ WVE
$3.42 +0.01 (+0.22%)
As of: Nov 11, 2026 · 2:53 PM EST

Wave Life Sciences (WVE) Short-term Investments (2022 - 2026)

Updated

Wave Life Sciences' Short-term Investments came in at $25.04 million for Q3 2022, up 0.2% from the prior quarter.

Analysis

Wave Life Sciences (WVE) Short-term Investments (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Wave Life Sciences 672.50 Mn -1.27 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 233.43 Mn
Sep 30, 2022 25.04 Mn
Jun 30, 2022 25.00 Mn
Mar 31, 2022 50.00 Mn
API Access

Wave Life Sciences Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=WVE&period=max&api_key=YOUR_API_KEY